Business Segments Shenzhen YHLO Biotech Co., Ltd.
Equities
688575
CNE100005204
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.17 CNY | -1.57% |
|
-4.63% | -7.25% |
| 04-28 | Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 03-17 | Shenzhen YHLO Biotech receives notice of administrative penalty from regulator | RE |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Diagnostic Kits / Equipment | 1.18B | 3.98B | 2.05B | 2.01B | - | |||
Total Assets | 2.14B | 4.21B | 3.81B | 4.42B | - | |||
Interest Expense | -11.22M | -8.41M | -6.25M | -12.18M | - | |||
Income Tax Expense | 23.91M | 165M | 54.91M | 39.5M | - | |||
CAPEX | -373M | -565M | -663M | -593M | - | |||
EBT | 228M | 1.19B | 334M | 312M | - | |||
D&A | 97.47M | 143M | 195M | 245M | - | |||
Operating Income | 227M | 1.2B | 341M | 315M | - | |||
Net Income | 205M | 1.01B | 355M | 302M | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
China | - | 2.2B | 1.85B | 1.72B | - | |||
Overseas | 179M | 1.73B | 164M | 250M | - | |||
Northeast Region | 24.78M | - | - | - | - | |||
Northwest District | 30.89M | - | - | - | - | |||
Southwest Region | 36.04M | - | - | - | - | |||
Northern Region | 60.84M | - | - | - | - | |||
Central China | 62.89M | - | - | - | - | |||
East China | 226M | - | - | - | - | |||
South China | 513M | - | - | - | - |
- Stock Market
- Equities
- 688575 Stock
- Financials Shenzhen YHLO Biotech Co., Ltd.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition